Background The endometrial echopattern on the day of human chorionic gonadotropin (HCG) administration and its relationship to the outcome of pregnancy after assisted reproductive treatment (ART) cycles was analyzed, prospectively. MaterialsAndMethods This study conducted between 2013 to 2014. The endometrial pattern was evaluated prospectively on the day of administration of HCG in 280 ART cyc...

In this paper, we examine critically the notion of “Triple Bottom Line” accounting. We begin by asking just what it is that supporters of the Triple Bottom line idea advocate, and attempt to distil specific, assessable claims from the vague, diverse, and sometimes contradictory uses of the Triple Bottom Line rhetoric. We then use these claims as a basis upon which to argue (a) that what is soun...

abstract background: triple therapy with a proton pump inhibitor, clarithromycin and amoxicillin and quadruple therapy with a proton pump inhibitor, bismuth citrate, metronidazole and amoxicillin have been proposed in maastricht 2000 as the optimal treatment of helicobacter pylori infection. we aimed to compare these two regimens in iranian pediatric patients. methods: a randomized clinical tri...

 ABSTRACT Background: Triple therapy with a proton pump inhibitor, clarithromycin and amoxicillin and quadruple therapy with a proton pump inhibitor, bismuth citrate, metronidazole and amoxicillin have been proposed in Maastricht 2000 as the optimal treatment of Helicobacter pylori infection. We aimed to compare these two regimens in Iranian pediatric patients. Methods: A randomized clinical tr...

Recent developments in the Triple Bottom Line reporting literature suggest a need for standards that ensure consistency, openness, transparency and inclusivity in the Triple Bottom Line reports produced. These standards, it is argued, provide assurances to stakeholders about the quality of a Triple Bottom Line report, and should lead to more inclusive business-stakeholder relations. The link be...

OBJECTIVE The objective of this study was to assess the efficacy, safety and tolerability of vonoprazan, a novel potassium-competitive acid blocker, as a component of Helicobacter pylori eradication therapy. DESIGN A randomised, double-blind, multicentre, parallel-group study was conducted to verify the non-inferiority of vonoprazan 20 mg to lansoprazole 30 mg as part of first-line triple the...